Anti-LRRC8A antibody [EPR23402-29]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal LRRC8A antibody. Suitable for IP, WB and reacts with Mouse, Rat, Human samples. Cited in 2 publications.
View Alternative Names
KIAA1437, LRRC8, SWELL1, UNQ221/PRO247, LRRC8A, Volume-regulated anion channel subunit LRRC8A, Leucine-rich repeat-containing protein 8A, Swelling protein 1, HsLRRC8A
- IP
Supplier Data
Immunoprecipitation - Anti-LRRC8A antibody [EPR23402-29] (AB254389)
LRRC8A was immunoprecipitated from 0.35 mg C2C12 (mouse myoblasts myoblast), whole cell lysate 10 μg with ab254389 at 1/30 dilution (2 μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab254389 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : C2C12 whole cell lysate 10 μg
Lane 2 : ab254389 IP in C2C12 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab254389 in C2C12 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds
All lanes:
Immunoprecipitation - Anti-LRRC8A antibody [EPR23402-29] (ab254389)
Predicted band size: 94 kDa
false
- WB
Lab
Western blot - Anti-LRRC8A antibody [EPR23402-29] (AB254389)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure times : Lane 1-4 : 81 seconds; Lane 5-8 : 3 minutes
All lanes:
Western blot - Anti-LRRC8A antibody [EPR23402-29] (ab254389) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg
Lane 3:
C2C12 (mouse myoblasts myoblast), whole cell lysate at 20 µg
Lane 4:
NIH/3T3 (mouse embryonic fibroblast), whole cell lysate at 20 µg
Lane 5:
Mouse thymus tissue lysate at 20 µg
Lane 6:
Rat thymus tissue lysate at 20 µg
Lane 7:
Mouse lung tissue lysate at 20 µg
Lane 8:
Rat lung tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 94 kDa
false
Related conjugates and formulations (1)
-
Anti-LRRC8A antibody [EPR23402-29] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LRRC8A forms heteromeric complexes with related proteins LRRC8B LRRC8C LRRC8D and LRRC8E. These complexes constitute the VRAC channels which are important for regulating cell volume in response to osmotic changes a process called regulatory volume decrease. LRRC8A's involvement in this process is essential for cell survival under fluctuating environmental conditions as it prevents cellular swelling and lysis by allowing ions and osmolytes to exit the cell.
Pathways
Researchers have linked LRRC8A to the PI3K-AKT signaling pathway and the apoptotic pathway. In the context of the PI3K-AKT pathway LRRC8A contributes to cell survival and growth regulation interacting with proteins like AKT. Within the apoptotic pathway through VRAC activity LRRC8A plays a role in apoptosis regulation facilitating the release of apoptogenic factors that trigger programmed cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 22:1034 PubMed39550567
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7075 PubMed37925509
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com